# Human Umbilical Cord Mesenchymal Stem Cells Treatment in Sepsis

> **NCT06882811** · EARLY_PHASE1 · RECRUITING · sponsor: **Daping Hospital and the Research Institute of Surgery of the Third Military Medical University** · enrollment: 180 (estimated)

## Conditions studied

- Sepsis

## Interventions

- **BIOLOGICAL:** CD83-positive MSC
- **BIOLOGICAL:** regulatory MSC
- **OTHER:** control solution

## Key facts

- **NCT ID:** NCT06882811
- **Lead sponsor:** Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-22
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06882811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06882811, "Human Umbilical Cord Mesenchymal Stem Cells Treatment in Sepsis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06882811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*